Susquehanna Growth Equity (SGE) has appointed David Spitz as a Senior Adviser in the firm’s Portfolio Value Creation team. In this role, Spitz will mentor and support SGE portfolio company leadership teams while helping SGE extend relationships with entrepreneurs in the Carolinas and beyond. Spitz is the CEO of ChannelAdvisor
Louise Lawlor has been appointed as Group Chief Financial Officer at Centaur Fund Services in Dublin.Read the full story at Hedgeweek…
A company backed by global private equity firm Permira, has agreed to acquire Neuraxpharm, a European specialty pharmaceutical company focused on the treatment of the central nervous system (CNS) from funds advised by Apax Partners. Financial details of the transaction have not been disclosed. With its unique understanding of the
ARQIS has advised AVS Verkehrssicherung on the acquisition of SRV Verkehrstechnik.SRV was founded in 1990 to meet the high demand for infrastructure services in the former East German states. The professional application of white or yellow road markings in paint, hot or cold plastic is the specialty of SRV. Services
AMP Capital has agreed to acquire a majority stake in VX Fiber, an international infra tech fibre business headquartered in Sweden, on behalf of investors in its infrastructure equity strategy. VX Fiber has existing operations in South Africa and the UK and is targeting an advanced pipeline of opportunities in the
Funds advised by Apax Partners (the “Apax Funds”) have agreed to sell their controlling stake in Neuraxpharm, a leading European specialty pharmaceutical company focused on the treatment of central nervous system disorders (CNS), to funds advised by Permira. Financial details of the transaction have not been disclosed. With a
Medicxi, a European life sciences investment firm, has held the closing of Medicxi Secondary 1 (MS1) in connection with the completion of an “Exit & Reinvest” type of structured secondary transaction. The interests in six clinical and preclinical stage companies held by Index Ventures Life VI, a dedicated life sciences fund
Odyssey Investment Partners (Odyssey) is to acquire ProPharma Group from Linden Capital Partners. Financial terms of the transaction have not been disclosed. Founded in 2001, ProPharma Group is a leading provider of regulatory and compliance services to pharmaceutical, biotechnology and medical device customers. The Company’s primary service offerings include regulatory affairs,
BGF is investing in Calnex Solutions plc, an established provider of test and measurement solutions for the global telecommunications sector, as part of its proposed admission to trading on AIM. The admission is expected to take place on 5 October 2020. Headquartered in Linlithgow and founded in 2006, Calnex designs
LBO France has appointed Thibaud Nonotte-Varly as Investor Relations Director, effective 1 September 2020.Nonotte-Varly is joining LBO France from Rothschild & Co, where he was Investor Relations Director for eight years. LBO partnered with lower and middle market Private Equity specialists Raw Selection on making the appointment and in particular
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
